Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Tissue Engineered Construction Based on a Synthetic Tricalcium Phosphate and Autologous Multipotent Mesenchymal Stromal Cells Obtained From Oral Mucosa

NCT02209311 is registered in ClinicalTrials.gov with Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation as lead sponsor.

NCT NCT02209311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02209311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Tissue Engineered Construction Based on a Synthetic Tricalcium Phosphate and Autologous Multipotent Mesenchymal Stromal Cells Obtained From Oral Mucosa
Lead sponsor
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2014
Completion date
March 31, 2018
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar bone atrophy, alveolar bone loss, partially edentulous maxilla